Dalton Transactions
Paper
8.0 Hz, Ar), 7.13 (q, 2H, J = 8.0 Hz, Ar), 7.26 (t, 1H, J = 8.0 Hz,
Ar), 7.33 (q, 2H, J = 8.0 Hz, Ar), 8.24 (d, 1H, J = 8.0 Hz, Ar),
13.08 (s, 1H, OH). 13C NMR (100 MHz, CDCl3): δ (ppm) 25.1,
48.5, 66.4, 98.0, 116.7, 117.8, 118.5, 119.3, 120.3, 125.0, 128.6,
129.1, 129.5, 133.3, 150.2, 160.2, 161.0, 163.6, 164.5.
MS ESI+ 362.04.
5.3 N,N′-Benzylidenebisbenzamide
1H NMR (400 MHz, DMSO): δ 7.04 (t, J = 8 Hz, 1H, CH), 7.31
(t, J = 8 Hz, 1H, ArH), 7.38 (t, J = 8 Hz, 2H, ArH), 7.48 (m, 6H,
ArH), 7.89 (d, J = 8 Hz, 2H, ArH), 9.07 (d, J = 8 Hz, 2H, NH).
13C NMR (100 MHz, DMSO): δ 59.0, 126.8, 127.2, 128.8, 132.1,
134.1, 138.9, 166.2.
Fig. 9 Recyclability of Ag nps@modified TEOS xerogel in the synthesis
of benzopyranopyrimidines (piperidine as the test substrate) and gem-
bisamides (benzaldehyde as the test substrate).
MS ESI+ 353 (M + 23).
5.4 N,N′-(3,4-Dimethoxyphenylmethylene)dibenzamide
Each time the amount of the catalyst was reduced due to
manual mishandling and for each run the amounts of the
corresponding reactants were adjusted. After each trial, the
catalyst was washed with warm water and ethanol followed by
drying in an oven at 50 °C to be reused for the next time.
1H NMR (400 MHz, DMSO): δ (ppm): 3.76 (6H, s, OCH3), 6.96
(q, 3H, J = 8 Hz), 7.11 (s, 1H), 7.48 (d, 4H, J = 8 Hz), 7.54 (d,
2H, J = 4 Hz), 7.84 (d, 4H, J = 8 Hz), 8.94 (d, 2H, J = 8 Hz, NH).
13C NMR (100 MHz, DMSO): δ (ppm): 165.9, 149.0, 148.9,
141.5, 134.4, 133.2, 131.9, 119.2, 111.9, 111.0, 59.1.
MS ESI+ 413.03 (M+).
4. Conclusion
So, we conclude the work with some new findings of silver
nanoparticles in the form of Ag nps@modified TEOS xerogel
as a recyclable nanocatalyst in the synthesis of benzopyrano-
pyrimidines and gem-bisamides in less time with efficient
yields. Moreover, the synthesis of benzopyranopyrimidine with
p-methoxybenzaldehyde has been successfully achieved too
and the mechanistic insights are also confirmed by the trap-
ping of the imine intermediate. Also the potential application
of the Ag nps@modified TEOS xerogel makes the synthesis of
such a nanocatalyst worthwhile.
Acknowledgements
We are thankful to IIT Mumbai for SEM-EDX and TEM ana-
lyses, to SAIF, Kochi for XRD and FTIR analyses and to the
Department of Chemistry, University of Jammu, for providing
facilities for UV, TGA and NMR analyses. Also, we are thankful
to IIIM Jammu for providing mass spectral analysis.
References
1 G.
K. Thirunavukkarasu, Dalton Trans., 2015, 44, 14975–14990.
2 G. Kour, M. Gupta, B. Vishwanathan and
K. Thirunavukkarasu, New J. Chem., 2016, 40, 8535–8542.
3 K. D. Bhatte, P. J. Tambade, K. P. Dhake and
B. M. Bhanage, Catal. Commun., 2010, 11, 1233–1237.
4 S. Chandra and A. Kumar, Int. J. Appl. Biol. Pharm. Technol.,
2011, 2, 78–85.
5 H. Cong, C. F. Becker, S. J. Elliott, M. W. Grinstaff and
J. A. Porco Jr., J. Am. Chem. Soc., 2010, 132, 7514–7518.
6 J. Davarpanah and A. R. Kiasat, Catal. Commun., 2013, 41,
6–11.
7 Q. Geng and J. Du, RSC Adv., 2014, 4, 16425–16428.
8 K. M. Manesh, A. I. Gopalan, K. P. Lee and S. Komathi,
Catal. Commun., 2010, 11, 913–918.
Kour,
M.
Gupta,
B.
Vishwanathan
and
5. Spectral data of some of the
synthesized compounds
5.1 2-(4-(Piperidin-1-yl)-5H-chromeno[2,3-d]pyrimidin-2-yl)
phenol
1H NMR (400 MHz, CDCl3): δ (ppm) 1.79 (s, 6H, 3CH2), 3.45 (s,
4H, N(CH2)2), 3.93 (s, 2H, CH2), 6.92 (t, 2H, 3J = 7.2 Hz, Ar),
6.99 (d, 1H, 3J = 8.0 Hz, Ar), 7.11 (t, 3H, 3J = 7.4 Hz, Ar), 7.20
(m, 3H, Ar), 7.35 (t, 1H, Ar), 13.5 (s, 1H, OH); 13C NMR
(100 MHz, CDCl3): δ (ppm) 24.3, 25.6, 25.9, 49.5, 97.5, 117.1,
117.5, 118.5, 118.8, 119.5, 124.4, 128.2, 128.5, 129.2, 132.8,
150.6, 160.4, 162.0, 165.2.
MS ESI+ 360.
5.2 2-(4-Morpholino-5H-chromeno[2,3-d]pyrimidin-2-yl)
phenol
9 Y. Feng, H. Yin, A. Wang and W. Xue, J. Cat., 2015, 326, 26–
37.
1H NMR (400 MHz, DMSO): δ (ppm) 3.49 (t, 4H, 2CH2, J = 10 N. Salam, A. Sinha, A. S. Roy, P. Mondal, N. R. Jana and
4 Hz), 3.78 (t, 4H, 3CH2, J = 6 Hz), 3.99 (s, 2H), 6.89 (t, 2H, J =
S. M. Islam, RSC Adv., 2014, 4, 10001–10012.
This journal is © The Royal Society of Chemistry 2017
Dalton Trans.